theophylline

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf alkaloid
bronchodilator
gptkbp:aroma odorless
gptkbp:ATCCode R03DA04
gptkbp:bioavailability variable (60–100%)
gptkbp:CASNumber 58-55-9
gptkbp:category gptkb:methylxanthine
stimulant
respiratory system drug
gptkbp:chemicalFormula C7H8N4O2
gptkbp:color white
gptkbp:discoveredBy gptkb:Albrecht_Kossel
gptkbp:discoveredIn 1888
gptkbp:eliminationHalfLife 8 hours (adults)
gptkbp:excretion gptkb:kidney
gptkbp:flavor bitter
gptkbp:foundIn gptkb:café
cocoa
gptkbp:hasInChIKey ZFXYFBGIUFBOJW-UHFFFAOYSA-N
gptkbp:hasSMILES Cn1cnc2c1c(=O)n(C)c(=O)n2
https://www.w3.org/2000/01/rdf-schema#label theophylline
gptkbp:IUPACName 1,3-dimethyl-7H-purine-2,6-dione
gptkbp:KEGGID D08452
gptkbp:legalStatus prescription only (varies by country)
gptkbp:mechanismOfAction adenosine receptor antagonist
phosphodiesterase inhibitor
gptkbp:meltingPoint 273 °C
gptkbp:MeSH_ID D013736
gptkbp:metabolism liver
gptkbp:molecularWeight 180.164 g/mol
gptkbp:pregnancyCategory C (US)
gptkbp:PubChem_CID 2153
2063
CHEMBL154
DB00277
gptkbp:relatedTo caffeine
theobromine
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect gptkb:arrhythmia
nausea
vomiting
insomnia
gptkbp:solubility 8 mg/mL (at 25 °C)
gptkbp:UNII 3G6A5W338E
gptkbp:usedFor asthma
chronic obstructive pulmonary disease
gptkbp:bfsParent gptkb:CYP1A2
gptkb:Erythromycin
gptkb:Fluoroquinolones
gptkb:riluzole
gptkbp:bfsLayer 5